Werewolf Therapeutics Correlations
HOWL Stock | USD 1.12 0.01 0.88% |
The current 90-days correlation between Werewolf Therapeutics and Ikena Oncology is 0.09 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Werewolf Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Werewolf Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Werewolf Therapeutics Correlation With Market
Good diversification
The correlation between Werewolf Therapeutics and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Werewolf |
Moving together with Werewolf Stock
Moving against Werewolf Stock
0.44 | WM | Waste Management | PairCorr |
0.41 | LUCD | Lucid Diagnostics | PairCorr |
0.36 | PG | Procter Gamble | PairCorr |
0.52 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.47 | T | ATT Inc Sell-off Trend | PairCorr |
0.43 | XOM | Exxon Mobil Corp Earnings Call Next Week | PairCorr |
0.41 | CVX | Chevron Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Werewolf Stock performing well and Werewolf Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Werewolf Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GLUE | 3.54 | (0.27) | 0.00 | (0.27) | 0.00 | 7.34 | 30.08 | |||
DSGN | 4.10 | (0.19) | 0.00 | (0.23) | 0.00 | 8.72 | 24.91 | |||
IKNA | 2.07 | (0.18) | 0.00 | (0.44) | 0.00 | 4.65 | 16.13 | |||
STOK | 3.45 | (0.43) | 0.00 | (0.31) | 0.00 | 7.03 | 20.29 | |||
EWTX | 2.65 | (0.40) | 0.00 | (0.31) | 0.00 | 4.89 | 17.09 | |||
DBTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CELC | 3.09 | (0.11) | 0.00 | (0.17) | 0.00 | 6.28 | 21.63 | |||
CCCC | 3.43 | (0.82) | 0.00 | (0.34) | 0.00 | 6.86 | 19.46 | |||
TALS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ACET | 3.39 | 0.08 | 0.03 | 0.84 | 3.68 | 9.78 | 20.19 |
Werewolf Therapeutics Corporate Management
Randi MD | Chief Officer | Profile | |
Timothy CPA | Treasurer CFO | Profile | |
Cynthia SeidelDugan | Chief Officer | Profile | |
Ellen MBA | Chief Officer | Profile | |
Daniel Hicklin | CEO, Founder | Profile | |
William Winston | Senior Research | Profile | |
Chulani Karunatilake | Chief Officer | Profile |